
Educational Modules to Optimize Antibiotic Prescribing and Evaluate Beta-Lactam Allergies
Infectious Diseases & Immunology
2023-12-08 – Present
Inaccurate antibiotic allergy labels frequently lead to the avoidance of first-line therapies like penicillins and cephalosporins, directly contributing to suboptimal patient outcomes and the rise of antimicrobial resistance (AMR). Because the clinical risks of mislabeling often exceed the risk of a true allergic reaction, de-labeling and formal reassessment have become urgent clinical priorities.
Building on previous PLP initiatives for surgical prophylaxis, this next phase prioritizes high-impact knowledge transfer. Through two key projects—professional educational modules and targeted provider and patient facing resources—the PLP equips clinicians with robust assessment protocols while empowering patients with essential health tools. Together, these initiatives expand treatment options and ensure the delivery of the safest, most effective care.
To address the global challenge of AMR, PLP is developing an innovative, asynchronous educational model led by Medical Director Dr. Lynora Saxinger. This multidisciplinary project translates complex stewardship practices into accessible, case-based learning for primary care, pharmacy, and nursing. The curriculum uniquely integrates reimagined clinical tools, insights from the Antimicrobial Use in Pregnancy project, and new patient-facing resources. Currently in the prototype phase, the modules will undergo rigorous pilot testing to ensure they serve as a practical, trusted resource for strengthening antibiotic stewardship across Alberta.
By transforming complex allergy data into practical tools and interactive education, this initiative removes the barriers to first-line antibiotic use—improving individual patient safety while protecting the long-term effectiveness of Alberta’s antimicrobial resources.